Yahoo Logo 1029x579.jpg
BIO-key International Announces Pricing of $3.75 Million Public Offering
October 30, 2023 14:21 ET | BIO-key International, Inc.
BIO-key International Announces Pricing of $3.75 Million Public Offering.
Arcutis logo.png
Arcutis Announces Pricing of $100 Million Public Offering
October 19, 2023 23:45 ET | Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing...
nxu-Logo-Black.png
Nxu, Inc. Announces $3.0 Million Public Offering of Common Stock
October 19, 2023 09:15 ET | Nxu Inc.
MESA, Ariz., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Nxu, Inc. (NASDAQ: NXU) (“Nxu” or “the Company”), a domestic technology company developing and manufacturing innovative EV charging and energy storage...
OmniQ Print Logo Black.png
OMNIQ Corp. Announces Closing of Public Offering
October 11, 2023 10:52 ET | OMNIQ Corp.
Salt Lake City, Utah, Oct. 11, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (Nasdaq: OMQS), a provider of Artificial Intelligence (AI)-based solutions, today announced the closing of its previously...
OmniQ Print Logo Black.png
OMNIQ Corp. Announces Proposed Public Offering of Common Stock
October 05, 2023 16:00 ET | OMNIQ Corp.
Salt Lake City, Utah, Oct. 05, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (Nasdaq: OMQS) (“OMNIQ Corp.” or the “Company”) today announced that it intends to offer to sell shares of its common stock...
Synlogic_Logo_Blue.png
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
October 03, 2023 16:15 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic_Logo_Blue.png
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
September 29, 2023 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Full Logo - OKYO .jpg
OKYO Pharma Announces Public Offering of Ordinary Shares
September 13, 2023 16:05 ET | OKYO Pharma LTD
LONDON and NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Screenshot_2.jpg
Blue Star Foods Announces Closing of $5 Million Public Offering
September 11, 2023 16:00 ET | Blue Star Foods Corp.
Miami, FL, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), today announced the closing of its previously announced public...
Group 139.png
Foremost Lithium Announces Closing of USD $4.0 Million Public Offering and NASDAQ Listing
August 24, 2023 13:26 ET | Foremost Lithium Resource & Technology Ltd.
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Foremost Lithium Resource & Technology Ltd. (Nasdaq: FMST, FMSTW) (CSE: FAT) ("Foremost Lithium" or the "Company"), an exploration...